These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5789339)

  • 21. The superior vena cava obstruction syndrome in bronchogenic carcinoma; pathologic physiology and therapeutic management.
    ROSWIT B; KAPLAN G; JACOBSON HG
    Radiology; 1953 Nov; 61(5):722-37. PubMed ID: 13112419
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of inoperable cancer of the lung.
    Wolf J
    Proc Natl Cancer Conf; 1970; 6():867-72. PubMed ID: 5458153
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytostatic infusion into bronchial arteries in bronchogenic carcinoma.
    Ekholm S; Albrechtsson U; Hellekant C; Jonsson K; Nyman U; Tylén U
    Ann Radiol (Paris); 1980; 23(4):346-8. PubMed ID: 7387096
    [No Abstract]   [Full Text] [Related]  

  • 25. Small-cell bronchogenic carcinoma; advances in treatment.
    Bergevin PR
    N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemoradiotherapy of non-small-cell bronchogenic carcinoma].
    Coupek P; Seneklová Z; Perková H; Kebedeová D
    Cas Lek Cesk; 2003; 142 Suppl 1():40-3. PubMed ID: 12924050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonsurgical treatment of pulmonary neoplasm.
    Shnider BI; Zevallos P
    Med Ann Dist Columbia; 1966 Oct; 35(10):528-30. PubMed ID: 5223193
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of cardiac catheterization in chemotherapy of bronchogenic carcinoma.
    MORRIS JF
    Cancer Chemother Rep; 1962 Feb; 16():537-42. PubMed ID: 14476256
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bronchogenic carcinoma and antiangiogenic therapy].
    Qi X; Rao W
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Aug; 23(8):492-4. PubMed ID: 11778266
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heroin in the treatment of incurably ill patients].
    Tybusz R; Ruszel K; Kielanowski T
    Pol Tyg Lek; 1974 Jul; 29(26):1129-30. PubMed ID: 4848866
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
    Klastersky J; Sculier JP
    Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 35. Etoposide--an effective single drug for treating bronchogenic carcinoma.
    Anderson G; Peel ET; Cheong CM; Broderick NJ
    Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
    Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 39. Prednisolone in terminal breast and bronchogenic cancer.
    Twycross RG; Guppy D
    Practitioner; 1985 Jan; 229(1399):57-9. PubMed ID: 2581241
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
    Denes AE; Presant CA; Bartolucci A
    Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.